Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100152097 Polymer-based sustained release device
06/17/2010US20100152096 Formulations for parenteral administration of amino-substituted (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones
06/17/2010US20100152095 Wound healing
06/17/2010US20100151589 Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof
06/17/2010US20100151588 Means and methods for diagnosing and treating cancer based on the frmd3 gene
06/17/2010US20100151466 Diagnosis and treatment of cervical cancer
06/17/2010US20100151458 Oligoribonucleotides and ribonucleases for cleaving rna
06/17/2010US20100151063 Serum uric acid level-decreasing agent and food and drink with label telling that food and drink decrease serum uric acid level
06/17/2010US20100151051 Anti-tumor drug, medicament, composition, and use thereof
06/17/2010US20100151035 Pharmaceutical compositions of poorly soluble drugs
06/17/2010US20100151033 Octreotide depot formulation with constantly high exposure levels
06/17/2010US20100151025 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
06/17/2010US20100151010 Medicament in a multilayer form
06/17/2010US20100151009 Formulations for delivering insulin
06/17/2010US20100151006 Cancer therapy sensitizer
06/17/2010US20100151003 Egfr binding peptides and uses thereof
06/17/2010US20100150997 Treatment of arthritis
06/17/2010US20100150990 Treatment of inflammation and/or endotoxic shock
06/17/2010US20100150985 Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same
06/17/2010US20100150970 Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction
06/17/2010US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
06/17/2010US20100150960 Compositions and methods for chitosan enhanced immune response
06/17/2010US20100150957 Peptides for active anti-cytokine immunization
06/17/2010US20100150950 Human antibodies that bind cd70 and uses thereof
06/17/2010US20100150949 Methods and compositions for modulating proline levels
06/17/2010US20100150947 Tolerance induction and maintenance in hematopoietic stem cell allografts
06/17/2010US20100150938 Methods and compositions for reducing inflammation and treating inflammatory disorders
06/17/2010US20100150933 Cytokine antagonists for neurological and neuropsychiatric disorders
06/17/2010US20100150931 Novel receptor for cd40l and uses thereof
06/17/2010US20100150930 Mage-11 as a marker for endometrial receptivity to embryo transplantation and a marker and therapeutic target in castration-recurrent prostate cancer
06/17/2010US20100150929 Peptide Associated with Rheumatic Fever (PARF) and Its Use as a Diagnostic Marker
06/17/2010US20100150928 Methods and compositions relating to zpa polypeptides
06/17/2010US20100150924 Regulation of myelination by nectin-like (necl) molecules
06/17/2010US20100150922 Use of TNF-alpha Inhibitors for Treating a Nerve Disorder Mediated by Nucleus Pulposus
06/17/2010US20100150916 huTNFR1 Selective Antagonists
06/17/2010US20100150915 Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
06/17/2010US20100150913 Organic compounds
06/17/2010US20100150912 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
06/17/2010US20100150909 PTHrP-DERIVED MODULATORS OF SMOOTH MUSCLE PROLIFERATION
06/17/2010US20100150903 Method for Treating Oncological Diseases
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150900 Dry Powder Fibrin Sealant
06/17/2010US20100150899 Pyrazolinone scavengers of free radical
06/17/2010US20100150898 Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
06/17/2010US20100150897 Compositions and methods for enzymatic treatment of lung disorders
06/17/2010US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150881 Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces
06/17/2010US20100150877 Osteopontin for the Prediction and Treatment of Cardiovascular Diseases
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010US20100150869 Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
06/17/2010US20100150868 Methods of Individually Optimizing Treatment for an Inflammation Associated Disease
06/17/2010US20100150867 Use of alpha-glucosidase inhibitors to treat alphavirus infections
06/17/2010US20100150866 Hepatitis C Virus Inhibitors
06/17/2010US20100150865 Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases
06/17/2010US20100150864 Antibodies that bind to il-18 and methods of purifying the same
06/17/2010US20100150863 Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
06/17/2010US20100150862 Methods of modulating maternal-fetal tolerance
06/17/2010US20100150861 Compostions with enhanced bioavailability and fast acting inhibitor or gastric acid secretion
06/17/2010US20100150860 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof
06/17/2010US20100150839 Compositions and Methods for Modulating Cognitive Function
06/17/2010US20100150834 High affinity ephb receptor binding compounds and methods of use thereof
06/17/2010DE102008062567A1 Dipeptoid-Prodrugs und ihre Verwendung Dipeptoid prodrugs and their use
06/17/2010DE102008062136A1 Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch A pharmaceutical composition based on peptide from camel milk
06/17/2010DE102008060844A1 Antimikrobielle Peptide aus Hydra Antimicrobial peptides from Hydra
06/17/2010DE102007050165B4 Stabilisierte Lösung, Verfahren zu deren Herstellung sowie deren Verwendung und Arzneimittel in Form einer stabilisierten Lösung Stabilized solution, process for their preparation and their use and medicaments in the form of a stabilized solution
06/17/2010CA2749588A1 Glycan-specific analytical tools
06/17/2010CA2746652A1 Crystalline forms of genistein
06/17/2010CA2746479A1 Combination of insulin with triazine derivatives and its use for treating diabetes
06/17/2010CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010CA2746258A1 Deuterated compounds as hepatitis c virus (hcv) inhibitors
06/17/2010CA2746256A1 Methods and compositions for specific modulation of mcl-1
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/17/2010CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010CA2744104A1 Cell-permeant peptide-based inhibitor of kinases
06/17/2010CA2729684A1 Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis
06/16/2010EP2196538A1 Conjugates prepared with aggregate-free proteins
06/16/2010EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/16/2010EP2196473A1 Mycobacterial antigens expressed during latency
06/16/2010EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
06/16/2010EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
06/16/2010EP2196213A1 Immunogenic LHRH compositions and methods relating thereto
06/16/2010EP2196211A1 Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c
06/16/2010EP2196210A1 A method for reducing the likelihood of preeclampsia in a subject in need thereof
06/16/2010EP2196209A1 Ctl inducer composition
06/16/2010EP2196202A1 Inflammation-inhibiting compounds Lys-Pro-Thr and Lys-Pro
06/16/2010EP2196197A1 Antiviral patch
06/16/2010EP2195339A2 A process for producing hepcidin
06/16/2010EP2195335A1 Diagnostic agent
06/16/2010EP2195333A1 Hsp70-based treatment for autoimmune diseases
06/16/2010EP2195332A1 Modulators of hypersensitivity reactions
06/16/2010EP2195038A1 Compositions suitable for treatment of spinal disease, disorder or condition
06/16/2010EP2195027A1 Methods of treating neurological autoimmune disorders with cyclophosphamide
06/16/2010EP2195025A1 Therapeutic antibody purification method and method of use
06/16/2010EP2195014A2 Use of g-csf for the treatment of stroke
06/16/2010EP2195013A1 Therapeutic use of a growth factor, metrnl
06/16/2010EP2195012A2 Use of a peptide as a therapeutic agent
06/16/2010EP2195011A1 Treatment with kallikrein inhibitors
06/16/2010EP2195007A1 Use of sco-spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands
1 ... 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 ... 3163